For research use only · Not for human or veterinary use · 21+ qualified researchers
Buy 2, Get 1 Free

WP-RT3

From $62.99 / vial

For in-vitro laboratory research use only. Not for human or veterinary use.

Reference compound: Retatrutide · CAS 2381089-83-2. Lyophilized powder, 10 mg, 20 mg. Single vial, Buy-2-Get-1 3-pack, or 10-vial lab kit. For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

Free Priority Mail shipping on orders over $149.00 · 1–3 business days
Orders confirmed by 2 PM CT ship the same business day · USPS Priority Mail 1–3 days
SKU: WP-RT3 Category: Tags: ,

For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

What WP-RT3 is

Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide engineered as a single-molecule agonist of three receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. A C20 fatty-diacid side chain promotes albumin binding and extends the half-life in the research literature.

Mechanism described in the literature

In receptor-pharmacology studies, retatrutide shows balanced activity at GIPR and GLP-1R with lower, but functionally relevant, potency at the glucagon receptor. The three pathways are studied together because they converge on cyclic-AMP signaling in pancreatic islets, the hypothalamus and the liver, with glucagon-receptor activity of interest for its role in hepatic energy expenditure and lipid turnover.

Research areas

  • Incretin and glucagon receptor signaling
  • Energy balance and adiposity models
  • Glucose homeostasis and islet biology
  • Hepatic steatosis (MASLD) models
  • Comparative pharmacology of mono-, dual- and tri-agonists

Specifications

Product code WP-RT3
Reference compound Retatrutide
CAS number 2381089-83-2
Molecular formula C221H342N46O68
Molecular weight 4731.3 g/mol
Composition 39-amino-acid peptide with a C20 fatty-diacid side chain; acetate salt
Form Lyophilized powder
Net content options 10 mg, 20 mg
Container 3 mL clear glass vial, crimped aluminum seal, flip-off cap
Storage Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.
Intended use In-vitro laboratory research only

Sizes and packs

Single vial at list price · 3-Pack = Buy 2, Get 1 Free (exactly 2× list) · 10-Vial Lab Kit = 25% off list. Select the size and pack above; the price updates.

Handling and storage

Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.

Vials ship sealed, cushioned and with a desiccant pack in plain packaging. Each vial is labeled with the product code, net content and the research-use designation. A packing slip lists the product codes and quantities ordered.

Frequently asked questions

Who can order?
Qualified researchers aged 21+ purchasing for in-vitro laboratory research. You confirm this at site entry and again at checkout.

When does it ship?
Orders confirmed by 2 PM CT ship the same business day by USPS Priority Mail (1–3 business days). Free shipping on orders over $149. Tracking is emailed when the carrier scans the label.

Can I return it?
All sales are final. Items that arrive damaged or incorrect are replaced when reported with photos within 72 hours of delivery — see Shipping & Returns.

References

  1. Coskun T, Urva S, Roell WC, et al.. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism 2022. doi:10.1016/j.cmet.2022.07.013
  2. Jastreboff AM, Kaplan LM, Frías JP, et al.. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine 2023. doi:10.1056/NEJMoa2301972
  3. Sanyal AJ, Kaplan LM, Frias JP, et al.. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature Medicine 2024. doi:10.1038/s41591-024-03018-2

This overview summarizes published literature about the reference compound and is provided for research context only. It is not a description of the properties, effects or uses of this product, which is supplied strictly for in-vitro laboratory research by qualified researchers. Nothing on this page is an instruction for preparation or use.

For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

Available sizes and packs

Weight N/A
Size

10 mg, 20 mg

Pack

Single vial, 3-Pack · Buy 2 Get 1 Free, 10-Vial Lab Kit

Launch offer — 15% off your first order with codeWELCOME15